During the past decade, Hainan General Hospital conducted 62 clinical trials. In the 10-year time frame, 62 clinical trials started and 6 clinical trials were completed, i.e. on average, 9.7% percent of trials that started reached the finish line to date. In the past 5 years, 40 clinical trials started and 6 clinical trials were completed. i.e. 15% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hainan General Hospital" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "BeiGene" with 4 trials sponsored, "Pfizer" with 4 trials sponsored, "Sun Yat-sen University" with 3 trials sponsored and "Sunshine Lake Pharma Co., Ltd." with 3 trials sponsored. Other sponsors include 43 different institutions and companies that sponsored additional 43 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hainan General Hospital" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "First Affiliated Hospital Xi'an Jiaotong University" with 2 trials as a collaborator, "First Affiliated Hospital of Chongqing Medical University" with 2 trials as a collaborator, "General Hospital of Ningxia Medical University" with 2 trials as a collaborator and "LanZhou University" with 2 trials as a collaborator. Other collaborators include 88 different institutions and companies that were collaborators in the rest 93 trials.

According to Clinical.Site data, the most researched conditions in "Hainan General Hospital" are "Hepatitis B, Chronic" (3 trials), "Non-Small Cell Lung Cancer" (3 trials), "Acute Migraine" (2 trials), "Advanced Hepatocellular Carcinoma (HCC)" (2 trials) and "Breast Neoplasms" (2 trials). Many other conditions were trialed in "Hainan General Hospital" in a lesser frequency.

Most popular intervention types in "Hainan General Hospital" are "Drug" (53 trials), "Device" (6 trials), "Other" (3 trials), "Biological" (2 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Cisplatin" (5 trials), "Tislelizumab" (4 trials), "Capecitabine" (3 trials) and "Oxaliplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hainan General Hospital" are 59 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "Hainan General Hospital". 1 are not yet recruiting, 30 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Hainan General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hainan General Hospital, 1 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 6 trials that are defined as “Not Applicable".